<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>8714175</identifier>
<setSpec>0213-4853</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>García Ruiz, P J</dc:author>
<dc:author>García de Yébeñes, J</dc:author>
<dc:author>Urcelay, V</dc:author>
<dc:author>Campos, J</dc:author>
<dc:author>San Martín, V</dc:author>
<dc:author>Castillo, F</dc:author>
<dc:author>Ferrer, A</dc:author>
<dc:author>Sánchez Bernardos, V</dc:author>
<dc:description xml:lang="en">We evaluated the safety and efficacy of Botulinum- A toxin (BTX) in patients with equinus deformity associated with cerebral palsy (CP). We prescribed BTX to six patients (all of whom had previously participated in a multicenter, randomized, double blind study of the same drug); treatment continued for at least 15 months. Four children showed striking improvement, being converted from toe-toe to consistent or occasional heel-toe gait. No side effects were observed. BTX appears to be safe and effective in patients with CP.</dc:description>
<dc:type>English Abstract</dc:type>
<dc:language>es</dc:language>
<dc:date>1996 Jan </dc:date>
<dc:title xml:lang="es">Tratamiento de la espasticidad asociada a parálisis infantil con toxina botulínica.</dc:title>
<dc:title xml:lang="en">[Botulinum A toxins in the treatment of spasticity in cerebral palsy during childhood].</dc:title>
<dc:publisher>Neurologia (Barcelona, Spain)</dc:publisher>
</metadata>
</record>
</pubmed-document>
